Search This Blog

Thursday, November 1, 2018

Teva Pharmaceutical beats by $0.13, misses on revenue


Teva Pharmaceutical (NYSE:TEVA): Q3 Non-GAAP EPS of $0.68 beats by $0.13; GAAP EPS of -$0.27 misses by $0.37.
Revenue of $4.53B (-19.4% Y/Y) misses by $20M.
Shares +1.15% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)